Championing Cardiovascular and Diabetic Health: PlexCure’s Commitment to Quality and Accessibility
In a country like India, where non-communicable diseases account for over 60% of total deaths, cardiovascular and diabetic conditions have emerged as silent epidemics. The growing burden of lifestyle-related disorders is not only a public health concern but also a call for innovation, affordability, and widespread access to effective medications. At PlexCure Healthcare Pvt. Ltd., we’re answering that call-one quality formulation at a time.
The Heart of the Matter: Treating Cardiovascular Disease
Cardiovascular diseases (CVDs) are the top cause of death in India, with cases increasing alarmingly even among young populations. Our cardiovascular range is crafted with precision, taking into account the contemporary Indian lifestyle, developing treatment practices, and the latest in global medical science.
PlexCure provides an extensive range of reliable medications including:
- Rosuvastatin for cholesterol management
- Telmisartan and Telmisartan + Hydrochlorothiazide antihypertensive combinations,
- Clopidogrel + Aspirin antiplatelet combinations for post-MI and prevention of stroke.
All formulations are formulated with quality standards, focusing on therapeutic efficiency and patient safety.
Fighting Diabetes with Technology and Affordability
India has the world’s second-largest diabetic population. Effective management of diabetes not only involves blood sugar control but also holistic care in managing related risks such as cardiovascular disease and kidney damage.
Our portfolio of antidiabetic products ranges across:
- Glimepiride, Metformin, and Pioglitazone for standard glycemic control,
- Voglibose for post-prandial glucose control,
- Dapagliflozin and Sitagliptin, next-generation drugs targeting SGLT2 and DPP-4 pathways respectively, for overall metabolic benefits.
These products are designed for both mono and fixed-dose combinations, allowing personalized treatment strategies while facilitating improved compliance.
Why PlexCure Excels
- Doctor-Centric Strategy: Each product is supported with clear, concise, and informative promotional materials intended for clinicians and medical representatives.
- Patient-First Formulations: Our focus is not just on treatment but on improving quality of life. Our medicines are formulated to ensure maximum efficacy with minimal side effects.
- Quality with Affordability: By leveraging efficient manufacturing practices and a strong distribution network, PlexCure ensures affordability without compromising on quality.
Looking Ahead, PlexCure is not just a pharma firm-we’re a healthcare partner. As we extend our reach into more parts of India, our mission remains unchanged: to enable healthcare professionals and enhance patient care in the cardiovascular and diabetic space.
Stay updated with us as we unveil more cutting-edge solutions, patient education solutions, and affordable medicines to redefine chronic care in India.
Let’s cure with care-PlexCure, together.
